BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 29216909)

  • 1. Which measuring site in ankylosing spondylitis is best to detect bone loss and what predicts the decline: results from a 5-year prospective study.
    Deminger A; Klingberg E; Lorentzon M; Geijer M; Göthlin J; Hedberg M; Rehnberg E; Carlsten H; Jacobsson LT; Forsblad-d'Elia H
    Arthritis Res Ther; 2017 Dec; 19(1):273. PubMed ID: 29216909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low bone mineral density of vertebral lateral projections can predict spinal radiographic damage in patients with ankylosing spondylitis.
    Kim JW; Chung MK; Lee J; Kwok SK; Kim WU; Park SH; Ju JH
    Clin Rheumatol; 2019 Dec; 38(12):3567-3574. PubMed ID: 31402392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteoporosis in ankylosing spondylitis - prevalence, risk factors and methods of assessment.
    Klingberg E; Lorentzon M; Mellström D; Geijer M; Göthlin J; Hilme E; Hedberg M; Carlsten H; Forsblad-d'Elia H
    Arthritis Res Ther; 2012 May; 14(3):R108. PubMed ID: 22569245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vertebral fractures in ankylosing spondylitis are associated with lower bone mineral density in both central and peripheral skeleton.
    Klingberg E; Geijer M; Göthlin J; Mellström D; Lorentzon M; Hilme E; Hedberg M; Carlsten H; Forsblad-D'Elia H
    J Rheumatol; 2012 Oct; 39(10):1987-95. PubMed ID: 22896024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-Term Treatment With TNF-Alpha Inhibitors Improves Bone Mineral Density But Not Vertebral Fracture Progression in Ankylosing Spondylitis.
    Beek KJ; Rusman T; van der Weijden MAC; Lems WF; van Denderen JC; Konsta M; Visman I; Nurmohamed MT; van der Horst-Bruinsma IE
    J Bone Miner Res; 2019 Jun; 34(6):1041-1048. PubMed ID: 30690799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The value of researches, which assess bone mineral density and bone metabolism in patients with ankylosing spondylitis, in detecting osteoporosis].
    Przepiera-Bedzak H
    Ann Acad Med Stetin; 2007; 53(3):39-47. PubMed ID: 18595484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of secukinumab on bone mineral density and bone turnover biomarkers in patients with ankylosing spondylitis: 2-year data from a phase 3 study, MEASURE 1.
    Braun J; Buehring B; Baraliakos X; Gensler LS; Porter B; Quebe-Fehling E; Haemmerle S
    BMC Musculoskelet Disord; 2021 Dec; 22(1):1037. PubMed ID: 34903218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of osteoporosis and vertebral fractures and related factors in patients with ankylosing spondylitis.
    Ulu MA; Batmaz İ; Dilek B; Çevik R
    Chin Med J (Engl); 2014; 127(15):2740-7. PubMed ID: 25146606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utility of DXA scanning and risk factors for osteoporosis in ankylosing spondylitis-A prospective study.
    Magrey MN; Lewis S; Asim Khan M
    Semin Arthritis Rheum; 2016 Aug; 46(1):88-94. PubMed ID: 27162010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Etanercept Increases Bone Mineral Density in Ankylosing Spondylitis, but Does Not Prevent Vertebral Fractures: Results of a Prospective Observational Cohort Study.
    van der Weijden MA; van Denderen JC; Lems WF; Nurmohamed MT; Dijkmans BA; van der Horst-Bruinsma IE
    J Rheumatol; 2016 Apr; 43(4):758-64. PubMed ID: 26879348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone loss in ankylosing spondylitis: does syndesmophyte formation have an influence on bone density changes?
    Kaya A; Ozgocmen S; Kamanli A; Ardicoglu O
    Med Princ Pract; 2009; 18(6):470-6. PubMed ID: 19797924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biomarkers of bone metabolism in ankylosing spondylitis in relation to osteoproliferation and osteoporosis.
    Klingberg E; Nurkkala M; Carlsten H; Forsblad-d'Elia H
    J Rheumatol; 2014 Jul; 41(7):1349-56. PubMed ID: 24931960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prevalence of vertebral fractures in mild ankylosing spondylitis and their relationship to bone mineral density.
    Mitra D; Elvins DM; Speden DJ; Collins AJ
    Rheumatology (Oxford); 2000 Jan; 39(1):85-9. PubMed ID: 10662879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone mineral density improves during 2 years of treatment with bisphosphonates in patients with ankylosing spondylitis.
    Arends S; Wink F; Veneberg J; Bos R; van Roon E; van der Veer E; Maas F; Spoorenberg A
    Br J Clin Pharmacol; 2021 Feb; 87(2):644-651. PubMed ID: 32530102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Higher Level of Dickkopf-1 is Associated with Low Bone Mineral Density and Higher Prevalence of Vertebral Fractures in Patients with Ankylosing Spondylitis.
    Rossini M; Viapiana O; Idolazzi L; Ghellere F; Fracassi E; Troplini S; Povino MR; Kunnathully V; Adami S; Gatti D
    Calcif Tissue Int; 2016 May; 98(5):438-45. PubMed ID: 26645432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severity of Sacroiliitis and Erythrocyte Sedimentation Rate are Associated with a Low Trabecular Bone Score in Young Male Patients with Ankylosing Spondylitis.
    Kang KY; Chung MK; Kim HN; Hong YS; Ju JH; Park SH
    J Rheumatol; 2018 Mar; 45(3):349-356. PubMed ID: 29335346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Femoral bone mineral density is associated with vertebral fractures in patients with ankylosing spondylitis: a cross-sectional study.
    Jun JB; Joo KB; Her MY; Kim TH; Bae SC; Yoo DH; Kim SK
    J Rheumatol; 2006 Aug; 33(8):1637-41. PubMed ID: 16881119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of PA spine, lateral spine, and femoral BMD measurements to determine bone loss in ankylosing spondylitis.
    Ulu MA; Çevik R; Dilek B
    Rheumatol Int; 2013 Jul; 33(7):1705-11. PubMed ID: 23274443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measuring bone density in axial spondyloarthropathy: Time to turn things on their side?
    Fitzgerald G; Anachebe T; McCarroll K; O'Shea F
    Int J Rheum Dis; 2020 Mar; 23(3):358-366. PubMed ID: 31909570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatocyte growth factor is a potential biomarker for osteoproliferation and osteoporosis in ankylosing spondylitis.
    Torres L; Klingberg E; Nurkkala M; Carlsten H; Forsblad-d'Elia H
    Osteoporos Int; 2019 Feb; 30(2):441-449. PubMed ID: 30306221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.